Dr. Scott Ramsey

For the Media

Dr. Scott Ramsey

Dr. Scott Ramsey is a member of Fred Hutch's Public Health Sciences Division and a director of Hutchinson Institute for Cancer Outcomes Research (HICOR). He studies comparative effectiveness analysis; cost effectiveness analysis, health economics and cancer outcomes research. 

Resources for more information

  • Overview of Scott Ramsey's Research
    Comparative effectiveness analysis; cost effectiveness analysis, health economics, cancer outcomes research.
  • Scott Ramsey – Brief Curriculum Vitae
    Appointments, affiliations and researcher interests.
    Hutchinson Institute for Cancer Outcomes Research (HICOR) is a research institute at Fred Hutch whose mission is to improve cancer prevention, detection and treatment in ways that will reduce the economic and human burden of cancer—ultimately leading to better outcomes for patients.
  • Public Health Sciences Division
    Using large populations as our laboratory, our researchers look for links between cancer and its possible triggers, from diet and lifestyle to environmental and genetic factors.


Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.


Photos / Graphics / Video


Download photos and view video of Scott Ramsey.

Related Stories

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.